Roche Holding AG (ROG)’s top-selling drug Rituxan effectively cured most cases of a rare and deadly skin disease in a patient study that suggests the medicine may replace steroids as the standard treatment. In a trial among 22 people with…
- Accueil
- Qui sommes-nous
- Vivant avec P/P
- Recherche
- Impliquez-vous
- Actualités & Info
- Forums de discussion
